SCHEMBL4155093

SCHEMBL4155093

CCCCCCCCCCCCN(CCCCCCCCCCCC)C(=O)CC

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.50
CA1 P00915 3/20 0.50
CA9 Q16790 3/20 0.50
CA2 P00918 1/20 0.50
MGLL Q99685 1/20 0.45
ZDHHC20 Q5W0Z9 2/20 0.44
ZDHHC2 Q9UIJ5 1/20 0.44
DNM1 Q05193 3/20 0.44
S1PR2 O95136 1/20 0.44
S1PR1 P21453 1/20 0.44
S1PR3 Q99500 1/20 0.44
S1PR5 Q9H228 1/20 0.44
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP3 P08254 1/20 0.43
MMP8 P22894 1/20 0.43
CES2 O00748 3/20 0.42
CES1 P23141 3/20 0.42
GGPS1 O95749 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4300443 1.00 CA12 (0.50) CA12CA1CA9CA2MGLL
SCHEMBL4155142 1.00 CA12 (0.50) CA12CA1CA9CA2MGLL
SCHEMBL6542339 1.00 CA12 (0.50) CA12CA1CA9CA2MGLL
SCHEMBL4152693 1.00 CA12 (0.50) CA12CA1CA9CA2MGLL
SCHEMBL4148017 1.00 CA12 (0.50) CA12CA1CA9CA2MGLL
SCHEMBL4148175 1.00 CA12 (0.50) CA12CA1CA9CA2MGLL
SCHEMBL4146283 1.00 CA12 (0.50) CA12CA1CA9CA2MGLL
SCHEMBL4155059 1.00 CA12 (0.50) CA12CA1CA9CA2MGLL
SCHEMBL4148813 0.98 CA12 (0.48) CA12CA1CA9CA2MGLL
SCHEMBL10795632 0.91 MGLL (0.52) CA12CA1CA9CA2MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119430569-A Treatment method of oil extraction wastewater based on solvent extraction 山东船舶技术研究院 2025-02-14 CN claimed
CN-114405059-A Extraction solvent organic phase for purifying citric acid and method for extracting and separating citric acid 山东金原德丰科技开发有限责任公司 2022-04-29 CN claimed
CN-119430569-A Treatment method of oil extraction wastewater based on solvent extraction 山东船舶技术研究院 2025-02-14 CN disclosed
CN-114405059-B Extraction solvent organic phase for purifying citric acid and method for extracting and separating citric acid 山东金原德丰科技开发有限责任公司 2023-03-28 CN disclosed
US-11597873-B2 Well treatment compositions and methods comprising certain microemulsions and certain clay control additives exhibiting synergistic effect of enhancing clay swelling protection and persistency FLOTEK CHEMISTRY, LLC (US) 2023-03-07 US disclosed
US-11407930-B2 Compositions and methods for enhancement of production of liquid and gaseous hydrocarbons FLOTEK CHEMISTRY, LLC (US) 2022-08-09 US disclosed
CN-114405059-A Extraction solvent organic phase for purifying citric acid and method for extracting and separating citric acid 山东金原德丰科技开发有限责任公司 2022-04-29 CN disclosed
US-20220073812-A1 DILUTED MICROEMULSIONS WITH LOW SURFACE TENSIONS FLOTEK CHEMISTRY, LLC (US) 2022-03-10 US disclosed
US-11254856-B2 Methods and compositions for use in oil and/or gas wells FLOTEK CHEMISTRY, LLC (US) 2022-02-22 US disclosed
US-20210371730-A1 WELL TREATMENT COMPOSITIONS AND METHODS COMPRISING CERTAIN MICROEMULSIONS AND CERTAIN CLAY CONTROL ADDITIVES EXHIBITING SYNERGISTIC EFFECT OF ENHANCING CLAY SWELLING PROTECTION AND PERSISTENCY FLOTEK CHEMISTRY, LLC (US) 2021-12-02 US disclosed
US-11180690-B2 Diluted microemulsions with low surface tensions FLOTEK CHEMISTRY, LLC (US) 2021-11-23 US disclosed
WO-2014153102-A1 METHODS AND COMPOSITIONS FOR USE IN OIL AND/OR GAS WELLS CESI CHEMICAL INC. (US) 2014-09-25 WO disclosed
US-20140284057-A1 METHODS AND COMPOSITIONS FOR USE IN OIL AND/OR GAS WELLS CESI CHEMICAL INC. (US) 2014-09-25 US disclosed
US-20140284053-A1 METHODS AND COMPOSITIONS FOR USE IN OIL AND/OR GAS WELLS CESI CHEMICAL INC. (US) 2014-09-25 US disclosed
US-20090247407-A1 Glyceride Ester Derivatives of Herbicidal Compounds and Compositions Thereof NUFARM AUSTRALIA LIMITED (AU) 2009-10-01 US disclosed
EP-2001830-A1 GLYCERIDE ESTER DERIVATIVES OF HERBICIDAL COMPOUNDS AND COMPOSITIONS THEREOF NUFARM AUSTRALIA LIMITED (AU) 2008-12-17 EP disclosed
WO-2007112505-A1 GLYCERIDE ESTER DERIVATIVES OF HERBICIDAL COMPOUNDS AND COMPOSITIONS THEREOF NUFARM AUSTRALIA LIMITED (AU) 2007-10-11 WO disclosed
EP-1667519-A1 SURFACTANT/SOLVENT MIXTURES Bayer CropScience GmbH (DE) 2006-06-14 EP disclosed
WO-2005036962-A1 SURFACTANT/SOLVENT MIXTURES BAYER CROPSCIENCE GMBH (DE) 2005-04-28 WO disclosed
US-20050064004-A1 Surfactant/solvent mixtures BAYER CROPSCIENCE GMBH (DE) 2005-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247407-A1 Glyceride Ester Derivatives of Herbicidal Compounds and Compositions Thereof PYM1, GRM4, GPR4 CA12 2144/4885CA1 1138/4885CA9 1533/4885
US-20050064004-A1 Surfactant/solvent mixtures C1R, C1S, HRH4 CA12 3178/4885CA1 3829/4885CA9 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.